-
Suzetrigine (CAS: 2649467-58-1)
API’s Name Indication Innovator Patent Expiry Date(The U.S) Suzetrigine Analgesic Vertex Pharmaceuticals Dec.4,2040 -
Semaglutide (CAS: 910463-68-2)
API’s Name Indication Innovator Patent Expiry Date(The U.S) Semaglutide Type2 diabetes,lose weight Novo Nordisk Dec.05,2031 -
Sugammadex Sodium
API’s Name Indication Specification US DMF EU DMF CEP Sugammadex Sodium Neuromuscular blockade In-House -
Sacubitril Hemicalcium
API’s Name Indication Specification US DMF EU DMF CEP Sacubitril Hemicalcium In-House -
Sofosbuvir
API’s Name Indication Specification US DMF EU DMF CEP Sofosbuvir HCV In-House 32048 √